This ‘minor’ bird flu strain has potential to spark human pandemic

This ‘minor’ bird flu strain has potential to spark human pandemic

2025-10-27 — Nature

Potential Human Pandemic from H9N2 Bird Flu Strain A team of scientists has found that the H9N2 bird flu virus, often considered minor, has adapted to human cells, sparking concerns of a p…


Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

2025-10-27 — FinanzNachrichten.de

Neumora Therapeutics Initiates Phase 1 Clinical Study of NMRA-898 Neumora Therapeutics, Inc. announced the initiation of a Phase 1 single-…

Designing Circuits with Parallel and Series Capacitors: A Step-by-Step Tutorial - GigWise

Designing Circuits with Parallel and Series Capacitors: A Step-by-Step Tutorial - GigWise

2025-10-27 — Gigwise

Designing Circuits with Parallel and Series Capacitors Capacitors are crucial components in electronic circuits, storing energy in an elec…

Ericsson, Nokia combine on research for 6G video

Ericsson, Nokia combine on research for 6G video

2025-10-27 — Mobile World Live

Ericsson, Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of-co…

Older Patients and Women Bear the Brunt of CTD-ILD Burden

Older Patients and Women Bear the Brunt of CTD-ILD Burden

2025-10-27 — Rheumatology Advisor

CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

2025-10-27 — FinanzNachrichten.de

Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…

Was Salt Lake City’s ‘No Kings’ protest a success? Organizers look back, and look ahead.

Was Salt Lake City’s ‘No Kings’ protest a success? Organizers look back, and look ahead.

2025-10-27 — The Salt Lake Tribune

Assessing the "No Kings" Protest in Salt Lake City The second "No Kings" protest in Salt Lake City has concluded, and organizers are refle…

‘That is not fair,’ says Piastri

‘That is not fair,’ says Piastri

2025-10-27 — Motor Sport Magazine

Tension at McLaren Lando Norris had priority over Oscar Piastri for a pitstop in Singapore, but this decision may have given an advantage …

Government reveals environmental regulation reforms in effort to boost housebuilding

Government reveals environmental regulation reforms in effort to boost housebuilding

2025-10-27 — Inside Housing

Government Reveals Environmental Regulation Reforms The government has announced changes to environmental regulations in an effort to boos…

Logistics Horizon Scanner: October 2025

Logistics Horizon Scanner: October 2025

2025-10-27 — Walker Morris

Logistics Horizon Scanner: October 2025 Walker Morris provides an overview of key developments in the logistics industry, noting that "tec…

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL

2025-10-27 — FinanzNachrichten.de

Pacira BioSciences Notified of Abbreviated New Drug Application Filing Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in non-opioid pai…

© 2025 pravobl.org News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice